Does histologic grade have a role in the management of head and neck cancers?

Journal of Clinical Oncology

Volumn 19, Issue 21, 2001, Pages 4107-4116

  Fortin, A ^a   Couture, C ^a   Doucet, R ^a   Albert, M ^a   Allard, J ^a   Tetu, B ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT PLANNING;

EID: 0035503535     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.21.4107     Document Type: Article

References (73)

1. Radiotherapy and concurrent chemotherapy: A strategy that improves locoregional control and survival in oropharyngeal cancer
2. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
3. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
4. Very accelerated radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial
5. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
6. Outcome of treatment of 160 patients with squamous cell carcinoma of the neck staged N3a
7. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
8. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
9. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
10. Reduction of distant metastases in head and neck cancer with concomitant chemotherapy
11. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer - The Department of Veterans Affairs Laryngeal Cancer Study Group
12. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group
13. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
14. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
15. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
16. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
17. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
18. Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract: The effect of clinical tumor parameters and course of illness
19. Development of distant metastasis after treatment of advanced-stage head and neck cancer
20. Distant metastasis in malignancies of the head and neck
21. Distant metastases from head and neck squamous cell carcinomas
22. Does node location affect the incidence of distant metastases in head and neck squamous cell carcinoma?
23. Metastatic patterns in squamous cell cancer of the head and neck
24. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients
25. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma
26. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database
27. Distant metastases in head and neck cancer patients who achieved loco-regional control
28. Lymph node prognostic factors in head and neck squamous cell carcinomas
29. Risk factors of metastasis in oral squamous cell carcinomas
30. Predicting factors for distant metastases in head and neck carcinomas: An analysis of 103 patients with locoregional control
31. Regional lymph node involvement affects the incidence of distant metastasis in tongue squamous cell carcinomas
32. Distant metastases in terminal head and neck cancer patients
33. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034
34. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study
35. Multivariate survival analysis using Cox's regression model
36. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model
37. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database
38. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts
39. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases
40. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
41. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis
42. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
43. Screening for distant metastases in patients with head and neck cancer
44. Role of chest CT scanning in the management of patients presenting with head and neck cancer
45. CT surveillance of the thorax in patients with squamous cell carcinoma of the head and neck: A preliminary experience
46. FDG PET evaluation of head and neck cancer: Value of imaging the thorax
47. Thallium-201 SPECT in the diagnosis of head and neck cancer
48. Re: Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
49. Second primary tumor incidence by primary index tumor and smoking status on a randomized chemoprevention study in head and neck squamous cell cancer
50. Value of grading squamous cell carcinoma of the head and neck
51. Nodal metastases: Predictive factors
52. Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients
53. Diagnostic evaluation of the neck
54. Clinical staging and operative reporting for multi-institutional trials in head and neck squamous cell carcinoma
55. Efforts to improve interobserver agreement in histopathological grading
56. Histological grading of breast carcinomas: A study of interobserver agreement
57. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma: Results of the Danish head and neck cancer study (DAHANCA) protocol 5-85
58. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors
59. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
60. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: Prognostic factors
61. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck: A randomized multicenter study of 5 versus 6 fractions per week - Preliminary report from DANACA 6 and 7 trial
62. Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: An analysis of the RTOG head and neck registry
63. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer
64. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: Targets for postoperative radiochemotherapy?
65. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: Tentative multivariate modelling system to predict the radiocurability of neck nodes
66. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer
67. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer
68. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer
69. Failure at distant sites following multimodality treatment for advanced head and neck cancer
70. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: Five-year results
71. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract